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Abstract
Background: Understanding the molecular basis of embryonic implantation is of great clinical and biological relevance. Little is
currently known about the adhesion receptors that determine endometrial receptivity for embryonic implantation in humans.
Methods and Principal Findings: Using two human endometrial cell lines characterized by low and high receptivity, we
identified the membrane receptor CD98 as a novel molecule selectively and significantly associated with the receptive
phenotype. In human endometrial samples, CD98 was the only molecule studied whose expression was restricted to the
implantation window in human endometrial tissue. CD98 expression was restricted to the apical surface and included in
tetraspanin-enriched microdomains of primary endometrial epithelial cells, as demonstrated by the biochemical association
between CD98 and tetraspanin CD9. CD98 expression was induced in vitro by treatment of primary endometrial epithelial cells
with human chorionic gonadotropin, 17-b-estradiol, LIF or EGF. Endometrial overexpression of CD98 or tetraspanin CD9
greatly enhanced mouse blastocyst adhesion, while their siRNA-mediated depletion reduced the blastocyst adhesion rate.
Conclusions: These results indicate that CD98, a component of tetraspanin-enriched microdomains, appears to be an
important determinant of human endometrial receptivity during the implantation window.
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Introduction
Endometrial receptivity is a self-limited period in which the
endometrial epithelium acquires a functional and transient ovarian
steroid-dependent status that allows blastocyst adhesion [1]. This
period, termed the ‘‘implantation window’’, lasts from 4–5 days to
9–10 days after progesterone production or administration. The
receptive window in humans is thus limited to days 19–24 of the
menstrual cycle [2].
To become receptive, the endometrium undergoes structural and
biochemical modifications induced by specific gene regulation. The
morphological changes include modifications of the plasma mem-
brane [3] and cytoskeleton [4,5]. The genomics of human endometrial
receptivity has also been explored in natural cycles [6,7,8] but
although different genes have been proposed to be essential for
receptivity (see [9] for review), none has been found to have a clinical
application, and evidence of function is in many cases lacking.
Embryonic implantation involves the sequential steps of
apposition, attachment and invasion [10]. Structural changes in
both players are dependant on a fine cross-talk between the
maternal endometrium and the blastocyst that is essential for
progress through each phase of implantation [10,11]. Similar to
the situation with leukocytes during extravasation, the first
interaction seems to rely on carbohydrate-ligands of L-selectin
expressed on the luminal epithelium at the time of apposition
[12]. However, L-selectin-deficient mice do not have fertility
problems [13]. Apart from L-selectin, the best characterized cell
adhesion molecules on the luminal surface of the endometrium
are avb3 integrin [14] and its ligand osteopontin, which has been
repeatedly found in genome-wide studies of human receptive
endometrium [6,7,8]. Mice deficient for CD147 (also known as
basigin or EMPRINN) were reported to have implantation defects
[15], and CD147 expression is restricted to the peri-implantation
window in rat [16]; however, in humans, endometrial expression
of this molecule appears to be less restricted [17]. HB-EGF
expression is induced by the embryo on the luminal epithelium,
ensuring growth-factor mediated crosstalk at the embryo-uterine
interface [18].
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Endometrial receptivity is probably not determined exclusively
by the expression of selective adhesion molecules, and a series of
cytoskeletal rearrangements is also likely to be important.
Endometrial pinopodes are hormone-dependent structures that
appear at the time of implantation at the apical membrane of the
epithelial endometrium and represent sites of preferential
blastocyst attachment [19]. Microvilli and specialized adhesive
structures such as endothelial docking structures are enriched in
tetraspanin-microdomains [20]. Mice deficient for tetraspanin
CD9 display a severe fertility reduction due to sperm-egg fusion
defects [21,22,23]; however, the function of CD9 in implantation
remains undetermined.
Different in vitro and ex vivo models and culture systems have
been used to mimic endometrial receptivity and implantation
[24,25], ranging from the use of endometrial cell lines [26], or
endometrium explants [27] to artificial ex vivo uterus [28]. In this
study we have employed two human endometrial cell lines
distinguished by different adhesiveness. RL95-2 is a human
epithelial cell line derived from a moderately differentiated
endometrial adenocarcinoma [29,30] that exhibits a more
pronounced adhesiveness than any other human endometrial
epithelial cell line for trophoblast-derived cells (JAR cells) [31] and
mouse blastocysts [4]. HEC-1-A, in contrast, is only weakly
adhesive, but exhibits a polarized distribution of integrins and a
more epithelial morphology [4]. Screening of these cell lines
identified up-regulated expression of CD98 and CD147 receptor
molecules in the high-receptivity cell line RL95-2, and their
potential function in endometrial receptivity was determined in
vitro. Our biochemical, immunohistological and functional data
demonstrated that CD98 is a key determinant of human
endometrial receptivity, whose expression is tightly regulated
during the implantation window.
Results
Adhesion receptor profiling of endometrial epithelial cell
lines and primary endometrial epithelial cells
Adhesion experiments with mouse blastocysts showed a
pronounced receptive phenotype for RL95-2 cells (81% blastocyst
adhesion) and a non-receptive phenotype for HEC-1-A cells
(46%); primary endometrial epithelial cells (EEC) cultured on
extracellular matrix show an intermediate blastocyst adhesion rate
of 67% [4].
In order to screen for adhesion receptors putatively involved in
human endometrial adhesivity to blastocysts, we directly measured
plasma membrane expression of adhesion receptors by means of a
flow-cytometry based array that included specific monoclonal
antibodies directed against 40 different adhesion receptors. In this
analysis the fingerprint of the three epithelial endometrial cultures
was overall very similar and different to that of leukocytes or
endothelial cells. As shown in Table 1 and Figure 1, all three
epithelial endometrial cultures expressed high levels of b1, a3 and
a6 laminin-binding integrins, intermediate levels of a2, low levels
of aVb3 integrins, and very low or undetectable levels of a1, a5, b2
or a4 integrins. The two cell lines showed a higher expression of
a6 integrin compared with primary cells. In addition, all
endometrial cultures expressed ICAM-1, CD44, CD59 and the
tetraspanins CD9, CD81 and CD151. The cells were negative for
the expression of the leukocyte markers ICAM-3, CD43 and
PSGL-1, and for the endothelial molecules VCAM-1 and CD31.
Endometrial cells were also negative for the expression of P, E and
L selectins. In contrast, consistent with their relevance in
endometrial receptivity [12], CD15, L-selectin ligands, were
detected on the cell surface of both primary EEC and in a small
percentage of cells from the receptive RL95-2 line, but not on
HEC-1-A cells. Of all the molecules tested, the only other adhesive
receptors that were more abundantly expressed in RL95-2 cells
were CD98hc (heavy chain) (about 6 fold higher than in HEC-1-A
and EEC cells) and CD147 (2.8 fold higher than in HEC-1-A cells
and 1.4 fold higher than in EEC).
CD98 expression is restricted to the implantation
window in human endometrium
CD98 is a multifunctional type II glycoprotein involved in
aminoacid transport [32], cell fusion [33] and integrin-dependent
spreading [34], whose gene deletion is embryonically lethal [35].
CD147 deficient mice have implantation defects [15]; however,
Table 1. Flow cytometry analysis of the expression of cell
adhesion molecules in endometrial epithelial cells and cell
lines.
Antigen EEC HEC-1-A RL95-2
Negative control 3.260.9 3.661.9 2.260.8
Integrin b1 184633 170644 79623*
vs EEC and HEC-1-A
Integrin a1 7.863.2 6.362.4 3.760.37
Integrin a2 4969 3268 2166
Integrin a3 46615 52613 2266
Integrin a4 3.860.5 4.660.8 561.2
Integrin a5 6.361.2 1164 2.360.3
Integrin a6 4267 133636* vs EEC 100629
Integrin aVb3 1762.4 2161.2 1163
Integrin b2 3.260.4 3.860.2 2.260.5
ICAM-1 36612 3365 1160.5
ICAM-2 3.360.2 4.360.5 1.860.3
ICAM-3 360.2 5.361.3 260.5
VCAM-1 3.960.4 560.75 2.760.7
CD31 3.860.3 662.4 2.560.2
CD43 360.4 4.861.5 1.860.7
CD44 38615 1968 1863
CD59 148610 57610 4165
MHC-I 394676 4569* vs EEC 5964* vs EEC
E-Selectin 2.260.2 5.261.4 1.860.3
P-Selectin 2.760.3 4.361.1 1.360.1
L-Selectin 2.960.1 4.661.2 1.860.3
CD15 91647 4.560.7 1562.3
PSGL-1 360.2 5.361.2 260.2
CD147 68627 3668 100612*
vs EEC and HEC-1-A
CD98 50610 54611 307637**
vs EEC and HEC-1-A
CD9 201650 157644 148632
CD81 1962.6 109613 20.560.5
CD151 3263.8 3368.6 10.660.9
Data shown are means 6 s.d. of the mean fluorescence intensity (MFI) of n = 2
for integrins a4 and b1, ICAM-2 and 3; VCAM-1, CD43, Selectins, PSGL-1; n = 5
for integrins b1, a2 and a3, ICAM-1, CD147 and CD98. n = 4 for the remaining
molecules. For optimal statistical analysis cytometer detectors were set to
include autofluorescence basal signal into the first log of the scale. * p,0.005
**p,0.001, ANOVA Newman-Keuls Multiple Comparison Test.
doi:10.1371/journal.pone.0013380.t001
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CD147 expression in humans is not so restricted to the
implantation window [17]. On the other hand, tetraspanin CD9
has been also reported to associate with ICAM-1 [20] and to be
expressed at the apical surface of endometrium in mice [36]. To
validate the results of our in vitro model in vivo, we analyzed the
expression of these adhesion molecules in human endometrium
throughout the menstrual cycle. ICAM-1, CD147 and CD9 were
detected in human endometrium (Figure 2A) [17,37,38]. ICAM-1
staining showed a high expression that peaked in the late secretory
phase in both stroma and epithelium. CD147 also stained
epithelial cells and its expression increased with the progression
of the menstrual cycle, peaking in the mid-secretory phase (group
4) (Fig. 2A), when implantation takes place; however, a stronger
staining was found on stroma. Tetraspanin CD9 staining was
restricted to glandular and luminar epithelium, with no expression
in the stromal compartment. No significant differences were
observed throughout the menstrual cycle, with CD9 showing a
weak-medium expression that declined only slightly at end of the
luteal phase. Interestingly, stroma and epithelium were negative
for CD98hc expression in the proliferative phase but it increased
to moderately positive in the mid-secretory phase (group 4), which
corresponds to the implantation window, in both luminar and
glandular epithelial cells and to a lower extent in stroma, (Fig. 2B).
Thus, CD9 and CD147 both occur on the luminal epithelium,
while CD98 might function as a receptivity determinant, since it
expression is undetectable outside the implantation window.
CD98 is polarized to the apical surface of endometrial
epithelial cells and is associated with tetraspanin-
enriched microdomains
To further analyze the role of CD98 embryonic adhesion, we
assessed its subcellular localization in monolayers of polarized
primary EEC (confirmed by intercellular staining of E-cadherin;
Fig. 3A). In contrast to what has been described in renal and
intestinal epithelial cells [39,40], CD98 is polarized to the apical
surface of endometrial epithelium, colocalizing at apical micro-
villae with tetraspanin CD9 (Fig. 3A and B and data not shown).
CD98hc apical staining was also evident in luminal epithelium in
vivo (Figure 2B). ICAM-1 and CD147 were found in both the
apical and the basolateral compartment. Beta1 integrins stained
the basal and lateral surfaces of primary EEC, while b3 was
apically expressed (Figure 3A and B).
CD98 has been shown to form molecular complexes with
CD147 [41], b1 and b3 integrins [34] and ICAM-1 [39] in
different cell types. We therefore analyzed the molecular
association of CD98 with both b1 and b3 integrins by
coimmunoprecipitation analysis in mildly restrictive conditions
(1% Brij 96) (Figure 3C). Consistent with their non-overlapping
subcellular localization, no association of CD98 could be detected
with b1 integrin in primary EECs. Both CD98 and the b3 integrin
are found in apical microvilli, and a very weak biochemical
association could be detected (Figure 3C), although these data
cannot be more conclusive due to the very low expression of the
aVb3 (Figure 1) or the b3 integrin chain (not shown) in our in vitro
cultured cells.
Colocalization with CD9 prompted us to explore the possible
insertion of CD98 in tetraspanin-enriched microdomains. Immu-
noprecipitation analysis in 1% Brij 96 showed a strong association
of ICAM-1 with CD9 in primary endometrial epithelial cell
monolayers (Fig. 3D), as previously reported for human endothe-
lial cells [20]. In contrast, no coimmunoprecipitation of CD98
with ICAM-1 could be detected. A weaker signal could be also
observed for CD9-CD98hc complexes, whereas no association
with CD9 was found for CD147. The anti-CD147 mAb was able
to weakly coimmunoprecipitate CD98, as previously described
[41]. These results suggest that CD98 forms two independent
complexes, with CD147 and with tetraspanins. Insertion into
tetraspanin-enriched microdomains might regulate CD98 polarity
and association with b3 integrin.
CD98 is induced by steroidal hormones in vitro in
cultured endometrial epithelial cells
The fact that CD98hc protein is exclusively expressed on the
implantation window suggests that its expression at the plasma
membrane might be dictated by extracellular stimuli such as
steroidal hormones. Treatment with progesterone did not
significantly alter the plasma membrane expression of CD98,
while exposure to 17-b-estradiol induced a significant increase of
CD98hc in primary endometrial cells (Figure 4A and B).
Remarkably, the greatest increment was observed upon treatment
Figure 1. Flow cytometry analysis of the expression of cell adhesion molecules in endometrial epithelial cells and cell lines.
Histogram profiles of the plasma membrane expression of CD9 (VJ1/20), ICAM-1 (HU5/3), b1 integrin (TS2/16), avb3 integrin (8D6), CD147 (VJ1/9) and
CD98 (FG1/10) on HEC-1-A (green) and RL95-2 (blue) cell lines as well as on primary EEC cultures (pink). Negative control pX63 is shown in gray line.
doi:10.1371/journal.pone.0013380.g001
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with both progesterone and 17-b-estradiol (Figure 4A and B).
Human chorionic gonadotropin (hCG) treatment was also able to
induce the expression of CD98 in primary EEC (Figure 4A and C).
Induction of the receptive phenotype in luminal endometrial
epithelium is also dictated by several paracrine factors secreted by
stromal cells [11,42]. We thus assessed CD98hc membrane
Figure 2. CD98 is expressed in the implantation window in human endometrium. A. Immunolocalization of ICAM-1 (HU5/3 mAb), CD147
(VJ1/9 mAb) and CD9 (VJ1/20 mAb) in human endometrium throughout the menstrual cycle. The micrographs show representative
immunohistochemical stains of luminal epithelium in group 4 samples (day 20), corresponding to the implantation window. Images correspond
to a 2006 magnification. The charts plot expression based on semi-quantitative staining analysis throughout the menstrual cycle in three to five
endometrial samples per group in epithelial glands (&), luminar epithelium (¤) or stroma (m). B. Immunolocalization of CD98 (anti-CD98 pAb) in
human endometrium throughout the menstrual cycle. Micrographs depict the luminar epithelium in the 5 menstrual cycle groups in sequence:
group1, = day 5, group 2 = day9, group 3 = day 15, group 4 = day 20, and group 5 = day 25. Images correspond to a 2006magnification. The chart
plots semi-quantitative analysis of the stainings throughout the menstrual cycle in three to five endometrial samples per group as in A.
doi:10.1371/journal.pone.0013380.g002
CD98 in Human Implantation
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expression by flow cytometry after stimulation of EEC with several
soluble factors that occur in vivo during implantation. In these
studies a marked upregulation of CD98 expression was observed
after treatment of primary cells with LIF (Leukemia Inhibitory
Factor), NGF (Nerve Growth Factor) and EGF (Epidermal
Growth Factor). No changes were observed upon Interleukin 1b
(IL-1b) treatment, while TGFb (Transforming Growth Factor)
significantly reduced CD98 membrane expression levels
(Figure 4D)
We next examined the localization of CD98 in endometrial cells
by confocal microscopy. Since spheroids stained strongly for CD98
expression, we performed these stainings with a blastocyst
adhesion system, in which mouse blastocysts were allowed to
adhere to confluent HEC-1-A cells. Samples were stained with
anti-human CD98hc to only visualize endometrial CD98. CD98
expression was clearly upregulated in the endometrial epithelial
cells that were in direct contact with the mouse blastocyst (Fig. 4E,
arrows). Collectively, these data demonstrate the paracrine-
dependent expression of CD98 in endometrial cells and the
induction of the molecule by blastocyst adhesion.
The expression level of CD98 in endometrium regulates
receptivity to mouse blastocyst adhesion
To directly assess whether CD98 was able to confer receptivity
to endometrial epithelium, cells of the poorly adhesive endometrial
cell line HEC-1-A were transiently transfected with GFP-tagged
constructs of the different adhesion molecules. JAR spheroids or
their conditioned media induced plasma membrane expression of
CD98 (not shown), because of their capacity to secrete significant
amounts of chorionic gonadotropin (hCG) [43]. To avoid this
effect, mouse hatching blastocysts were allowed to adhere onto
Figure 3. CD98 is inserted into tetraspanin-enriched microdomains on the apical surface of human endometrial cells. A. Confocal
analysis of adhesion molecule expression in cultures of polarized human primary endometrial epithelial cells. Vertical sections were obtained with
Leica Confocal Software (LASAF). Dashes mark the substratum position, whereas arrows point to the apical surface of the monolayer. B. Confluent
EEC monolayers were double stained for CD98 (FG1/10) and b1 integrin (TS2/16) or b3 integrin (P97) with CD9 (VJ1/20) and analyzed by confocal
microscopy. Nuclei were labeled with Hoechst (blue). Merged images and vertical sections of the double staining are also shown. Bars: 10 mm.
C. Confluent EEC monolayers were lysed in buffer containing 1% Brij 96 and lysates were immunoprecipitated with anti-b3 (P97), anti-b1 (TS2/16)
integrin chains mAbs or anti-CD98 serum. Non-immune Ig was included as negative control. Western blots were probed with TS2/16 for b1, and
rabbit polyclonal Abs against b3 integrin and CD98. Molecular weights (kDa) are shown. D. Confluent EEC monolayers were lysed in buffer containing
1% Brij 96 and lysates were immunoprecipitated with anti-CD9 (VJ1/20), anti-ICAM-1 (HU5/3) or anti-CD147 (VJ1/9) mAbs or anti-CD98 serum. Non-
immune Ig was included as negative control. Western blots were probed for CD9 (VJ1/20) and CD98 (anti-CD98 pAb). Different exposures of the same
membrane are shown for CD98 IP. Molecular weights (kDa) are shown.
doi:10.1371/journal.pone.0013380.g003
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transfected endometrial monolayers and the number of adhered
blastocysts analyzed after 24 h, or 48 h for silencing experiments
to increase basal adhesion levels. Overexpression of ICAM-1 or
the negative control CD4 had no significant effect on blastocyst
adhesion. In contrast, overexpression of CD9 produced a
significant increase in blastocyst adhesion, while siRNA mediated
CD9 silencing (diminished CD9 expression down to 40% of basal
expression, as determined by RT-PCR (not shown) or flow
cytometry Figure 5A, note that flow cytometry data are plotted on
a logarithmic scale) was able to significantly reduce blastocyst
adhesion rate (Fig. 5B).
Transfection of HEC-1-A with plasmids encoding myc-tagged
CD98hc, while they increased CD98 mRNA expression, did not
significantly alter plasma membrane protein expression analyzed
by flow cytometry. To overcome this problem, we infected cells
with a lentivirus encoding human CD98hc together with a GFP
infection reporter; this system achieved 2–10 fold overexpression
of CD98 on the plasma membrane of HEC-1-A cells (Figure 5C).
Lentiviral overexpression of CD98 produced complete adhesion of
near 100% of mouse blastocysts at 24 h (Figure 5D). To directly
demonstrate the role of CD98 in determining human receptivity,
we reduced CD98 membrane expression by lentiviral infection
with CD98-specific shRNA (30% as determined by flow
cytometry, to avoid compromising cell viability, Figure 5C).
Under these conditions, CD98 silencing significantly impaired
mouse blastocyst adhesion (Figure 5D). All these results suggest
that CD98 might be a crucial determinant of human endometrial
receptivity during the implantation window.
Discussion
Our results indicate that CD98 is an important determinant of
endometrial receptivity in humans. A number of in vitro and ex
vivo models and culture systems have been used to mimic the
Figure 4. Endometrial CD98 expression is induced by hormones in vitro. A. Flow cytometry analysis of the membrane expression of CD98
(FG1/10 mAb), ICAM-1 (HU5/3 mAb), CD147 (VJ1/9 mAb) and CD9 (VJ1/20 mAb) in EEC cells after treatment for 48 h with hCG (100 U/ml), 17-b-
estradiol (30 nM), progesterone (1 mM) or 17-b-estradiol plus progesterone. Data are the mean 6 s.e.m. of the Mean Fluorescence Intensity (MFI)
normalized to untreated cells in six independent primary EEC cultures. * p,0.02 ** p,0.00001 versus untreated cells in a Student T test. B. Western
blot analysis of CD98 expression in total lysates of primary EEC after treatment for 48 h with 17-b-estradiol (30 nM), progesterone (1 mM) or 17-b-
estradiol plus progesterone. GAPDH expression is shown as loading control. Numbers correspond to the densitometric analysis of CD98 protein
content corrected by GAPDH loading and normalized to untreated cells. Molecular weights (kDa) are shown. C. Western blot of CD98 expression in
total cell lysates of EEC after exposure to hCG (100 U/ml) for 48 h. a-tubulin expression is shown as loading control. Numbers correspond to the
densitometric analysis of CD98 protein content corrected by tubulin loading and normalized to untreated cells. Molecular weights (kDa) are shown.
D. Flow cytometry analysis of the membrane expression of CD98 in EEC cells after treatment for 48 h with IL1b (20 ng/ml), LIF (1000 U/ml), TGFb
(10 ng/ml), NGF (10 ng/ml), EGF (100 ng/ml) or IGF (1 mg/ml). Data are the mean 6 s.e.m. of the MFI normalized to untreated cells in four
independent experiments. * p,0.05 ** p,0.02 versus untreated cells in a Student T test. E. Mouse blastocysts were allowed to adhere to confluent
HEC-1-A monolayers, and samples were fixed and stained for human CD98 (FG1/10, shown in green), and analyzed by confocal microscopy. Nuclei
were labeled with Hoechst (blue). A pseudocolor image of CD98 staining intensity and a phase contrast image are shown. Mouse blastocyst is
outlined on the pseudocolor image. Bar: 50 mm.
doi:10.1371/journal.pone.0013380.g004
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characteristics of the endometrium during the window of
endometrial receptivity [24,44] and more precisely in the process
of implantation [45]. In this study we have used RL95-2 and
HEC-1-A tumor endometrial-derived cell lines as appropriate
models to identify markers of cellular receptivity. Since our aim
was to search for adhesion molecules that could be directly
involved in blastocyst adhesion, our initial screening was based on
direct measurements of the levels of expression at the plasma
membrane by flow cytometry. We show that the overall profile of
adhesion molecule expression in these endometrial cells is
comparable with that of primary endometrial epithelial cells.
Some alterations, such as those affecting MHC-I, a6 integrin and
CD9, might be related to the transformation process, since the
expression levels are similarly altered in both cell lines when
compared with primary cells. Of all the markers studied, only
CD15 L-Selectin ligand [12], CD98 and CD147 were found to be
increased specifically in the receptive RL95-2 cell line.
Our data show that CD98 expression in human endometrium is
strictly restricted to the implantation window in a hormone
dependent fashion, and its subcellular localization at the apical
surface of primary endometrial epithelial cells is consistent with a
role in blastocyst adhesion. Accordingly, CD98hc exogenous
overexpression turned HEC-1-A into a receptive cell line. Even
expanded blastocysts were found adhered to CD98 overexpressing
cells, indicating that they can bind to these endometrial cells as
soon as they emerge from the zona pellucida; moreover, reducing
Figure 5. Overexpression of CD9 and CD98 enhances the receptivity of HEC-1-A cells, while their silencing impairs adhesion. A. HEC-
1-A cells were transiently transfected with plasmid encoding the GFP-tagged versions of human ICAM-1 or CD9. 24 h after transfection cells were
trypsinized and labeled with the mAb specific for the transfected receptor (HU5/3 anti-ICAM-1 or VJ1/20 anti-CD9). Dot plots of GFP versus mAb
staining confirm that the GFP-expressing cells overexpress the corresponding receptor at the plasma membrane. For silencing CD9 expression, HEC-
1-A cells were transfected with siRNA oligonucleotide (filled histogram), or negative control oligonucleotide (white histogram) and stained for CD9
(VJ1/20) 48 h after transfection. B. HEC-1-A cells were transiently transfected with GFP-tagged versions of CD4, ICAM-1 and CD9, or with CD9-
targetted RNAi oligonucleotides, in independent experiments. Adhesion of mouse blastocysts to transfected cells was analyzed after co-culture for 24
or 48 h. Data are mean 6 s.e.m. of three independent experiments, expressed relative to the rate of adhesion on untransfected cells in each
experiment. The total number of blastocysts assessed in each condition were, CD4 n = 91, ICAM-1 n = 106, CD9 n = 169, CD9 siRNA n = 154. * p,0.05
(Mann-Whitney t test) compared with the corresponding control experiment with untransfected cells. Negative controls of adhesion ranged 50–60%
for overexpression experiments analyzed at 24 h, and 70% for silencing experiments analyzed at 48 h. C. Flow cytometry analysis of CD98 (FG1/10)
membrane expression after infection of HEC-1-A cells with lentivirus encoding human CD98 or CD98 shRNA. Expression was analyzed 72 h after
infection. Expression levels in cells infected with GFP control lentivirus are shown in the white histograms. D. HEC-1-A cells were infected with
lentivirus encoding GFP, CD98 plus GFP, or CD98 shRNA plus GFP. Three days after infection HEC-1-A monolayers were cocultured with mouse
blastocysts and adhesion was quantified after 24 or 48 h. Data are mean 6 s.e.m. Total number of blastocysts assessed were, non-infected n = 50, GFP
n = 61, CD98 n = 56, GFP n = 39, CD98 shRNA n = 64. * p,0.05 (Mann-Whitney t test) versus GFP.
doi:10.1371/journal.pone.0013380.g005
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CD98 plasma membrane expression levels by 30% had a clear
inhibitory effect on blastocyst adhesion. Further reduction in
CD98 membrane expression could not be attained without
impairing cell viability, because of the role of CD98 in aminoacid
transport [40]. Analysis of the role of endometrial CD98 in
implantation in mice has not been reported, since gene deletion of
CD98 is embryonically lethal [35]. Mating of heterozygous
animals showed empty decidual swellings, indicative of resorption
after implantation. However, CD98 mRNA levels were not
significantly reduced in heterozygous animals compared to wild
type [35]. Posttranscriptional regulation of CD98 by miRNA has
also been described [46]. Therefore, a complete deletion by
conditional knockouts in endometrial epithelial tissue would help
to explore this issue.
CD98 has been found associated with integrins and regulates
integrin-dependent spreading [34]. CD98 expression in polarized
endometrial cells is restricted to the apical surface of the
endometrial cell and does not associate with b1 integrins located
at the cell matrix interface. On the other hand, despite the low
expression of b3 integrin in in vitro cultures of EEC, it may be
associated to CD98 at apical microvilli. aVb3 integrin has been
shown to be specifically induced in luminal epithelium at the time
of implantation [14], and therefore, proposed to play a role in this
process. However, expression of this integrin did not correlate with
receptivity in vitro, and it was not significantly induced in primary
EEC by any of the soluble stimuli assessed (Yáñez-Mó et al.,
unpublished observations). Therefore, although CD98 may
regulate aVb3 function on endometrial epithelium in vivo, its
function on endometrial adhesion to the blastocyst seems to be at
least partially independent of this integrin. In other systems, CD98
has been shown to be directly involved in cell-cell interactions [47]
and in this context CD98 function appears to be affected by ecto-
phosphorylation [47]. Although, it is unclear in these models what
the putative ligand in the counterpart cell might be, CD98 binding
to galectins has been reported in other cell types [48]. Galectins,
which are frequently exposed on the cell plasma membrane, bind
to specific carbohydrates, which may be conserved interspecies,
thus explaining our data on CD98-dependent adhesion of mouse
blastocysts.
We also demonstrate here that CD98 is inserted into
tetraspanin-enriched microdomains. These data are in agreement
with a recent report by Wakabayashi et al.[49], that detected
CD98hc in immunoprecipitates of EWI-F, an immunologbulin
receptor associated to tetraspanins. In our experiments, performed
in more stringent detergent conditions, the yield of CD98 in CD9
immunoprecipitates and vice versa was significantly lower than
that found for ICAM-1, suggesting that the direct association of
CD98 might be with a different tetraspanin protein. Mammals
express 33 members of tetraspanin superfamily, but there are
currently no antibodies against most of them [50]. Furthermore,
CD98 has been reported to associate both with ICAM-1 [39] and
with b1 integrins [51,52]. Either or both of these molecular
associations might occur in the context of tetraspanin-enriched
microdomains, since these molecules also associate with tetra-
spanins. Association of CD98 with tetraspanins might be
important for its subcellular localization in different epithelial cell
types. Tetraspanin-associated ICAM-1 was suggested to be
responsible for CD98 basolateral localization in intestinal
epithelial cells [39]. In addition, tetraspanins are concentrated in
actin-rich structures such as microvilli and are connected to ERM
actin linkers [53]. Association of adhesion receptors with
tetraspanins has been demonstrated to be important for avidity
regulation of their adhesive functions [20,50]. In a previous report,
intrauterine injection of anti-CD9 antibodies greatly enhanced the
number of implanted embryos [54]. Although the authors focused
on the role of trophoblast CD9 in post-adhesion invasion steps,
crosslinking of endometrial CD9 might also enhance CD98 avidity
on the endometrial surface. Some tetraspanin-deficient mice have
been reported to be sterile as the result of a defect in sperm-egg
fusion [21,22,23,55]; however, a detailed analysis of implantation
was not reported. Our data reveal that overexpression of
tetraspanin CD9 in HEC-1-A cells greatly enhances blastocyst
adhesion. Although CD9 is constitutively expressed in luminal
epithelial cells throughout the menstrual cycle, the levels of this
tetraspanin in HEC-1-A were significantly lower than those of
primary EEC. The restoration of CD9 levels in the transfected
HEC-1-A cells might facilitate the adhesive function of associated
receptors, such as CD98. Moreover, in mice CD9 expression has
also been reported to be upregulated by steroid hormones and
found highly expressed in epithelial cells surrounding the
implanted embryo [56].
CD98 has also been proposed to be functionally linked to
CD147 [41]. However, CD98 only partially colocalized with
CD147 in primary endometrial epithelial cells, and appears to
engage in two independent molecular interactions, with CD147
and with CD9. CD147 is strongly expressed in the mouse embryo
trophoectoderm and uterine endometrium [16] and embryo
transfer to the uterus of CD147 null females demonstrates that
CD147 is necessary for implantation in mouse [15]. However, in
humans, CD147 is expressed in both stroma and epithelium in the
secretory phase [17]. We have corroborated these results, showing
that CD147 is expressed in the luminar and glandular epithelium,
but we also found staining in stromal cells and luminal epithelium
in the proliferative phase.
In sum, our results suggest that CD98 is a putative determinant
of endometrial receptivity. Moreover, the inclusion of CD98 into
tetraspanin-enriched microdomains suggests potential new thera-




Human endometrial samples were obtained for research after
written consent from patients, and the research was approved by
the Institutional Review Board on the use of human subjects in
research at the Instituto Valenciano de Infertilidad, and complies
with Spanish Law on Assisted Reproductive Technologies (35/
1988).
Cell culture and reagents
Human endometrial carcinoma HEC-1-A cells (HTB-112),
RL95-2 cells (CRL-1671) and JAR trophoblast-derived cells
(HTB-144) were purchased from the American Type Culture
Collection (ATCC; Rockville, MD). HEC-1-A cells were grown in
McCoy 5A medium supplemented with 10% fetal bovine serum
(FBS). RL95-2 cells were grown in a 1:1 mix of Dulbecco’s
modified Eagles medium (DMEM) and F-12K nutrient medium,
supplemented with 10% FBS.
Primary cell cultures of human endometrial epithelial cells
(EEC) were derived from human endometrium samples obtained
from biopsies as described [26]. Samples were obtained, after
written consent (see below), in the luteal phase from fertile patients
undergoing endometrial biopsy (ages 23–39 yr). Endometrial
samples were minced into fragments ,1 mm and subjected to
mild collagenase digestion. Endometrial epithelial cells were
isolated as previously described [25] and cultured to confluence
in a steroid-depleted medium composed of 75% Dulbecco
CD98 in Human Implantation
PLoS ONE | www.plosone.org 8 October 2010 | Volume 5 | Issue 10 | e13380
Modified Eagle Medium and 25% MCDB-105 (Sigma, Madrid,
Spain) containing antibiotics. This medium was supplemented
with 10% human albumin and 5 mg/mL insulin (Sigma). The
homogeneity of the cultures was determined according to the
morphologic characteristics and verified by an immunocytochem-
ical localization of cytokeratin, vimentin, and electron microscopy
scanning [25]. Confluence was reached between 4 and 6 days
17-b-estradiol, progesterone, hCG, EGF, TGFb, NGF, IGF
and IL1b were purchased from Sigma-Aldrich. LIF was from
Chemicon International, Inc. (CA, USA)
Endometrial biopsies
All samples were taken from women (ages 23–39 yr) undergoing
surgery for minor gynaecological procedures using an endometrial
suction curette (Pipelle, Laboratoire CCD, France). Women had
no underlying endometrial pathology and had regular menstrual
cycles of between 25 and 33 days. None of these women had
received a hormonal preparation in the 3 months preceding biopsy
collection. Endometrial samples were distributed in five groups
according to the phase in the cycle: group 1, early-mid
proliferative (days 1–8); group 2, late proliferate (days 9–14);
group 3, early secretory (days 15–18); group 4, mid secretory (days
19–22); and group 5, late secretory (days 23–28) according to the
criteria of Noyes et al [57].
Antibodies
Monoclonal antibodies (mAbs) used were as follows: anti-b1
integrin (TS2/16), anti-a1 integrin (TS2/7), anti-a2 integrin
(TEA1/41), anti-a3 integrin (VJ1/6), anti-a4 integrin (HP1/7),
anti-a5 integrin (SAM-1), anti-a6 integrin (GOH3), anti-avb3
integrin (8D6), anti-b2 integrin (TS1/18), anti-ICAM-1 (HU5/3),
anti-ICAM-2 (CBR-IC2/2), anti-ICAM-3 (HP2/19), anti-VCAM-
1 (4B9), anti-CD31 (TP1/15), anti-CD43 (TP1/36), anti-CD44
(HP2/9), anti-CD59 (VJ1/12), anti-MHC-I (W6.32), anti-E-
Selectin (TEA2/1), anti-P-Selectin (G1), anti-L-Selectin (Dreg55),
anti-CD15 (MY1), anti-PSGL1(PL1), anti-CD147 (VJ1/9), anti-
CD98hc (FG1/10), anti-CD9 (VJ1/20), anti-CD81 (I.33.2.2), and
anti-CD151 (LIA1/1)[20,58]. Anti-b3 integrin (P97) mAb was
kindly donated by Dr J. González-Rodrı́guez (Instituto de
Quı́mica Fı́sica, CSIC, Madrid, Spain).
The anti-CD98 heavy chain (CD98hc) and anti-b3 integrin
rabbit polyclonal antibodies were from Santa Cruz Biotechnolo-
gies (Santa Cruz, CA) and Cell Signaling (Beverly, MA),
respectively.
Negative controls used were either myeloma protein pX63
(IgG1, Kappa) or non-immune rabbit serum. Antibodies were
employed at 5–10 mg/ml for all applications.
DNA constructs and lentivirus
CD9 and ICAM-1-GFP constructs have been previously
described [20]. CD4-GFP construct was from Dr M. Davis
(Department of Microbiology and Immunology, Stanford Univer-
sity School of Medicine, CA). All HIV-1 derived lentiviral
constructs (pWPXK transfer vector, pCMVD8,74 helper packag-
ing construct and pMD2G vector encoding for envelope protein)
were provided by Dr. D. Trono (Ecole Polytechnique Federale de
Lausanne, Switzerland). The pWPXL-CD98 construct drives
expression of human CD98 from the EF1alpha promoter and
also contains a GFP expression cassette. CD98 shRNA was
targeted to TCGGGACATAGAGAATCTGAA sequence in
CD98 mRNA and inserted into pLenti6-GW-emGFP vector
(Invitrogen). The lentivirus expressing EGFP is an HIV-derived
third generation VSV-pseudotyped lentivirus in which EGFP
expression is driven by the cytomegalovirus early promoter/
enhancer. Lentivirus were produced by transient transfection into
293T cells by the calcium phosphate method, using a total of
45 mg mg of plasmid DNA on one 150 mm dish. The medium
(20 ml) was replaced after 14 to 16 h. After a further 24 h, the
conditioned medium was collected, cleared by low-speed centri-
fugation, and filtered through 0.45-mm-pore-size PVDF filters.
Viral titres were calculated by measuring transduction units (TU/
ml) and by qPCR of supernatants (particles/ml), and were around
107 to 108 TU/ml and at a ratio of 1:100 TU/particle.
Flow cytometry array analysis
RL95-2 and HEC-1-A human endometrial cell lines and
primary EEC were trypsinized and dispensed onto 96 w plates
preloaded with the different primary mAbs at a concentration of
5–10 mg/ml, followed by FITC-labelled Rabbit anti-mouse IgG
(DAKO). 40 different adhesion receptors were assayed including 9
integrin chains, 5 different tetraspanins, 3 Selectins, 11 Ig
receptors and 12 other adhesion molecules. Labeled cells were
analyzed by flow cytometry in a FACSCanto (Becton Dickinson).
Negative controls (mouse myeloma protein p3X63 (IgG1, Kappa)
followed by secondary antibody and secondary antibody alone)
were included as negative controls in every experiment. For
optimal statistical analysis cytometer detectors were set to include
autofluorescence basal signal into the first log of the scale. Trypsin
treatment was routinely assessed not to affect the binding of the
different antibodies employed.
When indicated, EEC confluent monolayers were treated for
the indicated times with the indicated hormone stimuli before
staining.
Immunohistochemistry
Immunohistochemistry was performed on 3–5 mm endometrial
sections of paraffin-embedded tissues using a DAKO LSAB
Peroxidase Kit. Briefly, sections were blocked with 4% BSA for
30 min at 37uC and incubated with 3% hydrogen peroxide for
5 min at room temperature (RT) prior to incubation (60 min, RT)
with primary antibodies. After 25 min incubation with the linker,
streptavidin-peroxidase was added for 15 min and the substrate-
cromogen solution (DAB) added for 5 min to stain the slides.
Slides were counterstained with Mayer’s hematoxilin. The slides
were mounted in entellan (Merck, Darmstadt Germany). Immu-
nostaining intensity was evaluated in at least three different
specimens and expression scored as absent (0), weak (1), moderate
(2) or strong (3) by three independent observers.
Immunofluorescence and confocal analysis
Confluent EEC monolayers were fixed with 2% paraformalde-
hyde and stained with the appropriate combination of mAb and
biotinylated mAb after mouse serum blocking. Confocal images
were obtained with a Leica TCS-SP5 confocal scanning laser
microscope and analyzed with the image processing Leica
Confocal Software and Photoshop 7.0 (Adobe Systems).
Immunoprecipitation
Confluent EEC monolayers were lysed in Tris-buffered saline
containing 1% Brij 96, 1 mM CaCl2, 1 mM MgCl2 and protease
inhibitors (Complete; Roche Applied Science). Cell lysates were
immunoprecipitated with 5 mg of the indicated antibody coupled
to protein-G-Sepharose. After washing six times with lysis buffer,
proteins bound to Sepharose beads were eluted by boiling in
sample buffer, separated by 10% SDS-PAGE under non-reducing
conditions, and transferred onto a nitrocellulose membrane
(Trans-Blot transfer medium; Bio-Rad).
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Cell transfection and infection
The cells, at 80–90% confluence, were transfected with plasmid
DNA or siRNA RNA duplexes [20] using with lipofectamine 2000
(Invitrogen, Carlsbad, CA). For lentiviral infection cells were
trypsinized and exposed in suspension to the lentivirus in a ratio of
100 MOI/cell before plating. Blastocyst adhesion was performed
24 h after transfection or 3 d after infection.
Mouse blastocyst adhesion assays
Female mice of strain B6C3F1 or DBA x C57BL were used.
Synchronous follicle development was triggered by intraperitoneal
administration of 10 or 7.5 IU eCG (Sigma-Aldrich), followed
48 h later by 10 or 5 IU hCG (Sigma-Aldrich), respectively.
Embryos were collected before natural implantation, either on day
2 post coitum and cultured for 3 days in S2 medium (Scandinavia
IVF Science) or on day 3.5 and cultured for 24 h in potassium
simplex optimization medium (KSOM). HEC-1-A monolayers
were incubated in 2% FBS containing media 24 h before the
incubation with the blastocysts and the integrity of the monolayer
checked at the end of the experiment. Degenerated embryos or
those with hatching defects were discarded. The zona pellucida
was not artificially removed. A number of 6–10 embryos were
added to confluent HEC-1A monolayers in 24 well plates and
were incubated for 24 h in overexpression experiments or 48 h for
silencing experiments. Attached embryos were counted under an
inverted microscope [27].
Acknowledgments
We thank Dr JC Ramı́rez and A. Garcı́a for lentivirus production and
Dr. S. Bartlett for English editing.
Author Contributions
Conceived and designed the experiments: FD CS FSM MYM. Performed
the experiments: FD AQ MAR AC MYM. Analyzed the data: FD CS MP
FSM MYM. Contributed reagents/materials/analysis tools: FD MAR
EGM HB AC SM AP MP FSM MYM. Wrote the paper: FD MYM.
References
1. Cross JC, Werb Z, Fisher SJ (1994) Implantation and the placenta: key pieces of
the development puzzle. Science 266: 1508–1518.
2. Navot D, Bergh PA, Williams M, Garrisi GJ, Guzman I, et al. (1991) An insight
into early reproductive processes through the in vivo model of ovum donation.
J Clin Endocrinol Metab 72: 408–414.
3. Murphy CR (2000) The plasma membrane transformation of uterine epithelial
cells during pregnancy. J Reprod Fertil Suppl 55: 23–28.
4. Martin JC, Jasper MJ, Valbuena D, Meseguer M, Remohi J, et al. (2000)
Increased adhesiveness in cultured endometrial-derived cells is related to the
absence of moesin expression. Biol Reprod 63: 1370–1376.
5. Thie M, Harrach-Ruprecht B, Sauer H, Fuchs P, Albers A, et al. (1995) Cell
adhesion to the apical pole of epithelium: a function of cell polarity. Eur J Cell
Biol 66: 180–191.
6. Borthwick J, Charnock-Jones D, Tom B, Hull M, Teirney R, et al. (2003)
Determination of the transcript profile of human endometrium. Mol Hum
Reprod 9: 19–33.
7. Carson D, Lagow E, Thathiah A, Al-Shami R, Farach-Carson M, et al. (2002)
Changes in gene expression during the early to mid-luteal (receptive phase)
transition in human endometrium detected by high-density microarray
screening. Mol Hum Reprod 8: 871–879.
8. Riesewijk A, Martin J, van Os R, Horcajadas JA, Polman J, et al. (2003) Gene
expression profiling of human endometrial receptivity on days LH+2 versus
LH+7 by microarray technology. Mol Hum Reprod 9: 253–264.
9. Horcajadas JA, Pellicer A, Simon C (2007) Wide genomic analysis of human
endometrial receptivity: new times, new opportunities. Hum Reprod Update 13:
77–86.
10. Dominguez F, Yanez-Mo M, Sanchez-Madrid F, Simon C (2005) Embryonic
implantation and leukocyte transendothelial migration: different processes with
similar players? FASEB J 19: 1056–1060.
11. Paria BC, Reese J, Das SK, Dey SK (2002) Deciphering the cross-talk of
implantation: advances and challenges. Science 296: 2185–2188.
12. Genbacev OD, Prakobphol A, Foulk RA, Krtolica AR, Ilic D, et al. (2003)
Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface.
Science 299: 405–408.
13. Robinson SD, Frenette PS, Rayburn H, Cummiskey M, Ullman-Cullere M,
et al. (1999) Multiple, targeted deficiencies in selectins reveal a predominant role
for P-selectin in leukocyte recruitment. Proc Natl Acad Sci U S A 96:
11452–11457.
14. Lessey BA, Damjanovich L, Coutifaris C, Castelbaum A, Albelda SM, et al.
(1992) Integrin adhesion molecules in the human endometrium. Correlation
with the normal and abnormal menstrual cycle. J Clin Invest 90: 188–195.
15. Kuno N, Kadomatsu K, Fan QW, Hagihara M, Senda T, et al. (1998) Female
sterility in mice lacking the basigin gene, which encodes a transmembrane
glycoprotein belonging to the immunoglobulin superfamily. FEBS Lett 425:
191–194.
16. Xiao LJ, Diao HL, Ma XH, Ding NZ, Kadomatsu K, et al. (2002) Basigin
expression and hormonal regulation in the rat uterus during the peri-
implantation period. Reproduction 124: 219–225.
17. Noguchi Y, Sato T, Hirata M, Hara T, Ohama K, et al. (2003) Identification
and characterization of extracellular matrix metalloproteinase inducer in human
endometrium during the menstrual cycle in vivo and in vitro. J Clin Endocrinol
Metab 88: 6063–6072.
18. Lim HJ, Dey SK (2009) HB-EGF: a unique mediator of embryo-uterine
interactions during implantation. Exp Cell Res 315: 619–626.
19. Bentin-Ley U (2000) Relevance of endometrial pinopodes for human blastocyst
implantation. Hum Reprod 15 Suppl 6: 67–73.
20. Barreiro O, Yanez-Mo M, Sala-Valdes M, Gutierrez-Lopez MD, Ovalle S, et al.
(2005) Endothelial tetraspanin microdomains regulate leukocyte firm adhesion
during extravasation. Blood 105: 2852–2861.
21. Le Naour F, Rubinstein E, Jasmin C, Prenant M, Boucheix C (2000) Severely
reduced female fertility in CD9-deficient mice. Science 287: 319–321.
22. Miller BJ, Georges-Labouesse E, Primakoff P, Myles DG (2000) Normal
fertilization occurs with eggs lacking the integrin alpha6beta1 and is CD9-
dependent. J Cell Biol 149: 1289–1296.
23. Miyado K, Yamada G, Yamada S, Hasuwa H, Nakamura Y, et al. (2000)
Requirement of CD9 on the egg plasma membrane for fertilization. Science 287:
321–324.
24. Lindenberg S (1991) Experimental studies on the initial trophoblast endometrial
interaction. Dan Med Bull 38: 371–380.
25. Mercader A, Valbuena D, Simon C (2006) Human embryo culture. Methods
Enzymol 420: 3–18.
26. Bentin-Ley U, Pedersen B, Lindenberg S, Larsen JF, Hamberger L, et al. (1994)
Isolation and culture of human endometrial cells in a three-dimensional culture
system. J Reprod Fertil 101: 327–332.
27. Landgren BM, Johannisson E, Stavreus-Evers A, Hamberger L, Eriksson H
(1996) A new method to study the process of implantation of a human blastocyst
in vitro. Fertil Steril 65: 1067–1070.
28. Bulletti C, Jasonni VM, Tabanelli S, Gianaroli L, Ciotti PM, et al. (1988) Early
human pregnancy in vitro utilizing an artificially perfused uterus. Fertil Steril 49:
991–996.
29. Tinel H, Denker HW, Thie M (2000) Calcium influx in human uterine epithelial
RL95-2 cells triggers adhesiveness for trophoblast-like cells. Model studies on
signalling events during embryo implantation. Mol Hum Reprod 6: 1119–
1130.
30. Way DL, Grosso DS, Davis JR, Surwit EA, Christian CD (1983) Character-
ization of a new human endometrial carcinoma (RL95-2) established in tissue
culture. In Vitro 19: 147–158.
31. John NJ, Linke M, Denker HW (1993) Quantitation of human choriocarcinoma
spheroid attachment to uterine epithelial cell monolayers. In Vitro Cell Dev Biol
Anim 29A: 461–468.
32. Chillaron J, Roca R, Valencia A, Zorzano A, Palacin M (2001) Heteromeric
amino acid transporters: biochemistry, genetics, and physiology. Am J Physiol
Renal Physiol 281: F995–1018.
33. Tsurudome M, Ito Y (2000) Function of fusion regulatory proteins (FRPs) in
immune cells and virus-infected cells. Crit Rev Immunol 20: 167–196.
34. Fenczik CA, Sethi T, Ramos JW, Hughes PE, Ginsberg MH (1997)
Complementation of dominant suppression implicates CD98 in integrin
activation. Nature 390: 81–85.
35. Tsumura H, Suzuki N, Saito H, Kawano M, Otake S, et al. (2003) The targeted
disruption of the CD98 gene results in embryonic lethality. Biochem Biophys
Res Commun 308: 847–851.
36. Chen M, Tung K, Coonrod S, Takahashi Y, Bigler D, et al. (1999) Role of the
integrin-associated protein CD9 in binding between sperm ADAM 2 and the egg
integrin alpha6beta1: implications for murine fertilization. Proc Natl Acad
Sci U S A 96: 11830–11835.
37. Park KR, Inoue T, Ueda M, Hirano T, Higuchi T, et al. (2000) CD9 is
expressed on human endometrial epithelial cells in association with integrins
alpha(6), alpha(3) and beta(1). Mol Hum Reprod 6: 252–257.
CD98 in Human Implantation
PLoS ONE | www.plosone.org 10 October 2010 | Volume 5 | Issue 10 | e13380
38. Schatz F, Krikun G, Baergen RN, Critchley HO, Kuczynski E, et al. (2006)
Intercellular adhesion molecule-1 expression in human endometrium: implica-
tions for long term progestin only contraception. Reprod Biol Endocrinol 4: 2.
39. Liu X, Charrier L, Gewirtz A, Sitaraman S, Merlin D (2003) CD98 and
intracellular adhesion molecule I regulate the activity of amino acid transporter
LAT-2 in polarized intestinal epithelia. J Biol Chem 278: 23672–23677.
40. Palacin M, Kanai Y (2004) The ancillary proteins of HATs: SLC3 family of
amino acid transporters. Pflugers Arch 447: 490–494.
41. Xu D, Hemler ME (2005) Metabolic activation-related CD147-CD98 complex.
Mol Cell Proteomics 4: 1061–1071.
42. Guzeloglu-Kayisli O, Kayisli UA, Taylor HS (2009) The role of growth factors
and cytokines during implantation: endocrine and paracrine interactions. Semin
Reprod Med 27: 62–79.
43. Hussa RO, Story MT, Pattillo RA (1975) Regulation of human chorionic
gonadotropin (hCG) secretion by serum and dibutyryl cyclic AMP in malignant
trophoblast cells in vitro. J Clin Endocrinol Metab 40: 401–405.
44. Lindenberg S, Hyttel P, Sjogren A, Greve T (1989) A comparative study of
attachment of human, bovine and mouse blastocysts to uterine epithelial
monolayer. Hum Reprod 4: 446–456.
45. Simon C, Mercader A, Garcia-Velasco J, Nikas G, Moreno C, et al. (1999)
Coculture of human embryos with autologous human endometrial epithelial
cells in patients with implantation failure. J Clin Endocrinol Metab 84:
2638–2646.
46. Nguyen HT, Dalmasso G, Yan Y, Laroui H, Dahan S, et al. (2010) MicroRNA-
7 modulates CD98 expression during intestinal epithelial cell differentiation.
J Biol Chem 285: 1479–1489.
47. Nguyen HT, Dalmasso G, Yan Y, Obertone TS, Sitaraman SV, et al. (2008)
Ecto-phosphorylation of CD98 regulates cell-cell interactions. PLoS One 3:
e3895.
48. Dong S, Hughes R (1996) Galectin-3 stimulates uptake of extracellular Ca2+ in
human Jurkat T-cells. FEBS Lett 395: 165–169.
49. Wakabayashi T, Craessaerts K, Bammens L, Bentahir M, Borgions F, et al.
(2009) Analysis of the gamma-secretase interactome and validation of its
association with tetraspanin-enriched microdomains. Nat Cell Biol 11:
1340–1346.
50. Yanez-Mo M, Barreiro O, Gordon-Alonso M, Sala-Valdes M, Sanchez-
Madrid F (2009) Tetraspanin-enriched microdomains: a functional unit in cell
plasma membranes. Trends Cell Biol 19: 434–446.
51. Feral CC, Zijlstra A, Tkachenko E, Prager G, Gardel ML, et al. (2007) CD98hc
(SLC3A2) participates in fibronectin matrix assembly by mediating integrin
signaling. J Cell Biol 178: 701–711.
52. Miyamoto YJ, Mitchell JS, McIntyre BW (2003) Physical association and
functional interaction between beta1 integrin and CD98 on human T
lymphocytes. Mol Immunol 39: 739–751.
53. Sala-Valdes M, Ursa A, Charrin S, Rubinstein E, Hemler ME, et al. (2006)
EWI-2 and EWI-F link the tetraspanin web to the actin cytoskeleton through
their direct association with ezrin-radixin-moesin proteins. J Biol Chem 281:
19665–19675.
54. Liu WM, Cao YJ, Yang YJ, Li J, Hu Z, et al. (2006) Tetraspanin CD9 regulates
invasion during mouse embryo implantation. J Mol Endocrinol 36: 121–130.
55. Rubinstein E, Ziyyat A, Prenant M, Wrobel E, Wolf JP, et al. (2006) Reduced
fertility of female mice lacking CD81. Dev Biol 290: 351–358.
56. Weimin L, Yujing C, Jing L, Zeng H, Ping Z, et al. (2007) The expression of
CD9 in the peri-implantation mouse uterus is upregulated in an ovarian steroid
hormone-dependent manner. Fertil Steril 87: 664–670.
57. Noyes RW, Hertig AT, Rock J (1975) Dating the endometrial biopsy.
Am J Obstet Gynecol 122: 262–263.
58. Yanez-Mo M, Alfranca A, Cabanas C, Marazuela M, Tejedor R, et al. (1998)
Regulation of endothelial cell motility by complexes of tetraspan molecules
CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at
endothelial lateral junctions. J Cell Biol 141: 791–804.
CD98 in Human Implantation
PLoS ONE | www.plosone.org 11 October 2010 | Volume 5 | Issue 10 | e13380
